Research reference only. Not medical advice. Most compounds are not FDA-approved. These are research chemicals, not for human consumption. Consult a qualified clinician.Read methodology Terms update on 18 Dec 2026

Peptide Comparison

Thymosin Alpha-1 vs Thymalin

Editorial breakdown of mechanism, evidence, decision criteria, and the misconceptions worth calling out.

Data-derived verdict

Thymosin Alpha-1 and Thymalin share the thymic class and carry roughly equivalent evidence (Approved in ~30 countries / Russian Clinical + Observational). On the catalogued data layer Thymosin Alpha-1 has a slight edge: more cited sources or efficacy data on file. For most research framings either pick is defensible; Thymosin Alpha-1's evidence base is currently denser.

Generated from catalog evidence-tier data, not editorial judgment. Both compounds share at least one mechanism class and this verdict reads the catalogued evidence tier of each, not specific trial nuance.

Evidence at a glance

Thymosin Alpha-1

Approved in ~30 countries

Thymalin

Russian Clinical + Observational

FDA-approved   Phase 3   Phase 2 / approved abroad   Anecdotal + animal   Preclinical / flagged

Side-by-side

Thymosin Alpha-1 Thymalin
Class Thymic peptide; immunomodulator Thymic peptide extract; immunomodulator
Drug class Immune Immune
Mechanism Activates TLR-9 and TLR-2; enhances T-cell maturation and NK cell function; restores immune balance Restores T-cell function; immune regulation in aged patients
Route SC injection IM
Half-life ~2 hrs Variable
Dosage (research) 1.6 mg SC 2x weekly (hepatitis); 0.9 mg/m² oncology trials 10 mg IM daily for 5-10 day courses
Evidence tier Approved in ~30 countries Russian Clinical + Observational
Research depth 250 indexed (PubMed 154 · CT 52 · EPMC 44) 177 indexed (PubMed 147 · CT 0 · EPMC 30)
Availability Compounding Restricted / Intl Rx Research
Reported risks Injection site reactions; rare hypersensitivity Limited Western evidence

Reported research data only. "Studied for" and "reported in literature" describe published research focus, not clinical recommendation. Most peptides catalogued here are not FDA-approved for human use.

Frequently asked questions

Should I pick Thymosin Alpha-1 or Thymalin?

Thymosin Alpha-1 and Thymalin share the thymic class and carry roughly equivalent evidence (Approved in ~30 countries / Russian Clinical + Observational). On the catalogued data layer Thymosin Alpha-1 has a slight edge: more cited sources or efficacy data on file. For most research framings either pick is defensible; Thymosin Alpha-1's evidence base is currently denser.

What is the difference between Thymosin Alpha-1 and Thymalin?

Thymosin Alpha-1 is classed as Thymic peptide; immunomodulator; Thymalin is classed as Thymic peptide extract; immunomodulator. Reported mechanism: Thymosin Alpha-1, Activates TLR-9 and TLR-2; enhances T-cell maturation and NK cell function; restores immune balance; Thymalin, Restores T-cell function; immune regulation in aged patients. Reported half-life: Thymosin Alpha-1, ~2 hrs; Thymalin, Variable. Routes in published studies: Thymosin Alpha-1, SC injection; Thymalin, IM.

Which has stronger evidence, Thymosin Alpha-1 or Thymalin?

Thymosin Alpha-1 has the stronger evidence base on PeptideHelper.org's five-step evidence scale, which runs from preclinical to FDA-approved. Thymosin Alpha-1 is graded Approved in ~30 countries, with 15 cited sources on its reference page and 250 indexed studies. Thymalin is graded Russian Clinical + Observational, with 2 cited sources on its reference page and 177 indexed studies.

Which is more accessible, Thymosin Alpha-1 or Thymalin?

Neither Thymosin Alpha-1 nor Thymalin is an FDA-approved drug. Catalog status: Thymosin Alpha-1, Compounding Restricted / Intl Rx; Thymalin, Research. Thymosin Alpha-1's nomination for FDA's bulk-substance lists was flagged by FDA and then withdrawn.

Are Thymosin Alpha-1 and Thymalin ever combined?

Thymosin Alpha-1 and Thymalin appear together in no stack catalogued on PeptideHelper.org, and the interaction engine raises no flag for the pair.

Open the PeptideHelper.org compare tool to add more compounds to this side-by-side and filter by evidence tier interactively.

Loading interactive view…